Inactivation of metabolic genes causes short- and long-range dys-regulation in Escherichia coli metabolic network

PloS One
Dinesh Kumar BarupalSankar Adhya

Abstract

The metabolic network in E. coli can be severely affected by the inactivation of metabolic genes that are required to catabolize a nutrient (D-galactose). We hypothesized that the resulting accumulation of small molecules can yield local as well as systemic effects on the metabolic network. Analysis of metabolomics data in wild-type and D-galactose non-utilizing mutants, galT, galU and galE, reveal the large metabolic differences between the wild-type and the mutants when the strains were grown in D-galactose. Network mapping suggested that the enzymatic defects affected the metabolic modules located both at short- and long-ranges from the D-galactose metabolic module. These modules suggested alterations in glutathione, energy, nucleotide and lipid metabolism and disturbed carbon to nitrogen ratio in mutant strains. The altered modules are required for normal cell growth for the wild-type strain, explaining why the cell growth is inhibited in the mutants in the presence of D-galactose. Identification of these distance-based dys-regulations would enhance the systems level understanding of metabolic networks of microorganisms having importance in biomedical and biotechnological research.

References

Apr 1, 1984·Journal of Bacteriology·H Rosenberg, C M Hardy
Oct 18, 2000·Nature·H JeongA L Barabási
May 15, 2002·The Journal of Biological Chemistry·Markus W Covert, Bernhard Ø Palsson
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Clay Fuqua, E Peter Greenberg
Feb 27, 2003·European Journal of Biochemistry·Eliane Fischer, Uwe Sauer
Jun 5, 2003·Nature Biotechnology·Vincent J J MartinJay D Keasling
Feb 6, 2004·Proceedings of the National Academy of Sciences of the United States of America·Masanori Arita
May 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Victor SpirinLeonid A Mirny
Jul 28, 2007·BMC Infectious Diseases·Dennis J Murphy, James R Brown
Mar 11, 2008·Nature Biotechnology·Markus Ringnér
May 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Anat KreimerEytan Ruppin
Jun 7, 2008·Microbiology and Molecular Biology Reviews : MMBR·Charles L Turnbough, Robert L Switzer
Jun 10, 2008·Nature Biotechnology·Adam M Feist, Bernhard Ø Palsson
Oct 7, 2008·Genome Research·Aswin S N SeshasayeeNicholas M Luscombe
Nov 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sang Jun LeeSankar Adhya
Mar 10, 2010·Nature Biotechnology·Jeffrey D OrthBernhard Ø Palsson
May 4, 2010·Applied and Environmental Microbiology·Dae-Hee Lee, Bernhard Ø Palsson
May 5, 2010·BMC Systems Biology·Kitiporn PlaimasRainer König
May 13, 2010·Molecular Systems Biology·Szymon JozefczukLothar Willmitzer
Mar 8, 2011·Nature Biotechnology·Yi-Xin HuoJames C Liao
May 14, 2011·The Journal of Biological Chemistry·Oliver FiehnTobias Kind
Oct 13, 2011·Molecular Systems Biology·Jeffrey D OrthBernhard Ø Palsson
Jul 24, 2012·Cell·Jonathan R KarrMarkus W Covert

❮ Previous
Next ❯

Methods Mentioned

BETA
environmental stress
environmental stresses
PCA

Software Mentioned

Cytoscape
MetaMapp
Statistica miner
Cytsocape
R

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.